154 related articles for article (PubMed ID: 31524099)
21. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
Devine A; Parmiter M; Chu CS; Bancone G; Nosten F; Price RN; Lubell Y; Yeung S
PLoS Negl Trop Dis; 2017 May; 11(5):e0005602. PubMed ID: 28542194
[TBL] [Abstract][Full Text] [Related]
22. A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India.
Saravu K; Tellapragada C; Kulavalli S; Xavier W; Umakanth S; Brahmarouphu G; Srinivas NK; Channabasavaiah JP; Bava A; Saadi AV; Guddattu V; Satyamoorthy K; Bhat K
Malar J; 2018 Sep; 17(1):321. PubMed ID: 30176897
[TBL] [Abstract][Full Text] [Related]
23. A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
Fukuda MM; Krudsood S; Mohamed K; Green JA; Warrasak S; Noedl H; Euswas A; Ittiverakul M; Buathong N; Sriwichai S; Miller RS; Ohrt C
PLoS One; 2017; 12(11):e0187376. PubMed ID: 29121061
[TBL] [Abstract][Full Text] [Related]
24. Cytochrome P450 2D6 profiles and anti-relapse efficacy of tafenoquine against
Dowd S; Chen N; Gatton ML; Edstein MD; Cheng Q
Antimicrob Agents Chemother; 2023 Dec; 67(12):e0101423. PubMed ID: 37971260
[No Abstract] [Full Text] [Related]
25. Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping.
Beck HP; Wampfler R; Carter N; Koh G; Osorio L; Rueangweerayut R; Krudsood S; Lacerda MV; Llanos-Cuentas A; Duparc S; Rubio JP; Green JA
J Infect Dis; 2016 Mar; 213(5):794-9. PubMed ID: 26500351
[TBL] [Abstract][Full Text] [Related]
26. Comment on 'The clinical pharmacology of tafenoquine in the radical cure of
Sharma R; Chen C; Tan L; Rolfe K; Fiţa IG; Jones S; Pingle A; Gibson RA; Goyal N; Sharma H; Bird P
Elife; 2024 Feb; 13():. PubMed ID: 38323802
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness analysis of G6PD diagnostic test for Plasmodium vivax radical cure in Lao PDR: An economic modelling study.
Aung YN; Tun STT; Vanisaveth V; Chindavongsa K; Kanya L
PLoS One; 2022; 17(4):e0267193. PubMed ID: 35468145
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic failure of primaquine and need for new medicines in radical cure of Plasmodium vivax.
Thomas D; Tazerouni H; Sundararaj KG; Cooper JC
Acta Trop; 2016 Aug; 160():35-8. PubMed ID: 27109040
[TBL] [Abstract][Full Text] [Related]
29. Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date.
Ebstie YA; Abay SM; Tadesse WT; Ejigu DA
Drug Des Devel Ther; 2016; 10():2387-99. PubMed ID: 27528800
[TBL] [Abstract][Full Text] [Related]
30. Exposure-Response Analyses for Tafenoquine after Administration to Patients with Plasmodium vivax Malaria.
Tenero D; Green JA; Goyal N
Antimicrob Agents Chemother; 2015 Oct; 59(10):6188-94. PubMed ID: 26248362
[TBL] [Abstract][Full Text] [Related]
31. The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific.
Elmes NJ; Nasveld PE; Kitchener SJ; Kocisko DA; Edstein MD
Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1095-101. PubMed ID: 18541280
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections.
Li Q; O'Neil M; Xie L; Caridha D; Zeng Q; Zhang J; Pybus B; Hickman M; Melendez V
Malar J; 2014 Apr; 13():141. PubMed ID: 24731238
[TBL] [Abstract][Full Text] [Related]
33. Comparison of tafenoquine (WR238605) and primaquine in the post-exposure (terminal) prophylaxis of vivax malaria in Australian Defence Force personnel.
Nasveld P; Kitchener S; Edstein M; Rieckmann K
Trans R Soc Trop Med Hyg; 2002; 96(6):683-4. PubMed ID: 12625150
[TBL] [Abstract][Full Text] [Related]
34. Killing of Plasmodium vivax by Primaquine and Tafenoquine.
Markus MB
Trends Parasitol; 2019 Nov; 35(11):857-859. PubMed ID: 31522991
[TBL] [Abstract][Full Text] [Related]
35. Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review.
Duparc S; Chalon S; Miller S; Richardson N; Toovey S
Malar J; 2020 Mar; 19(1):111. PubMed ID: 32169086
[TBL] [Abstract][Full Text] [Related]
36. Tafenoquine for the prophylaxis, treatment and elimination of malaria: eagerness must meet prudence.
Val F; Costa FT; King L; Brito-Sousa JD; Bassat Q; Monteiro WM; Siqueira AM; Luzzatto L; Lacerda MV
Future Microbiol; 2019 Oct; 14():1261-1279. PubMed ID: 31596137
[TBL] [Abstract][Full Text] [Related]
37. Monitoring the Efficacy of Chloroquine-Primaquine Therapy for Uncomplicated Plasmodium vivax Malaria in the Main Transmission Hot Spot of Brazil.
Ladeia-Andrade S; Menezes MJ; de Sousa TN; Silvino ACR; de Carvalho JF; Salla LC; Nery OA; de Melo GNP; Corder RM; Rodrigues PT; Ferreira MU
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782991
[TBL] [Abstract][Full Text] [Related]
38. Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum.
Wampfler R; Hofmann NE; Karl S; Betuela I; Kinboro B; Lorry L; Silkey M; Robinson LJ; Mueller I; Felger I
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005753. PubMed ID: 28732068
[TBL] [Abstract][Full Text] [Related]
39. [Plasmodium vivax malaria recurrence according to the use of primaquine: analysis of longitudinal descriptive studies].
Carmona-Fonseca J
Rev Bras Epidemiol; 2012 Sep; 15(3):488-503. PubMed ID: 23090298
[TBL] [Abstract][Full Text] [Related]
40. Treatment of relapsing Plasmodium vivax malaria during pregnancy.
Spiegelenberg JP; Bastiaens GJH; Hassing RJ
J Travel Med; 2021 Jul; 28(5):. PubMed ID: 34104968
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
